Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease

Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases

Chen, H., & Chan, D. C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp326 · Cited by 1,455 · see citing works

Role of oxidative stress in Alzheimer’s disease

HUANG, W.-J., ZHANG, X., & CHEN, W.-W. (2016) · Biomedical Reports · doi:10.3892/br.2016.630 · Cited by 1,023 · see citing works

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models

Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0275-4 · Cited by 935 · see citing works

Oxidative stress in Alzheimer’s disease

Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00040-5 · Cited by 895 · see citing works

Mitochondria and Mitochondrial Cascades in Alzheimer’s disease

Swerdlow, R. H. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170585 · Cited by 850 · see citing works

Excitotoxicity: Bridge to various triggers in neurodegenerative disorders

Mehta, A., Prabhakar, M., Kumar, P., Deshmukh, R. R., & Sharma, P. L. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.032 · Cited by 662 · see citing works

Alzheimer's Disease: From Pathology to Therapeutic Approaches

Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626 · see citing works

Evidence of neuronal oxidative damage in Alzheimer's disease.

Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) · Europe PMC (PubMed Central) · Cited by 600 · see citing works

Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

Smith, M. A., Hirai, K., Hsiao, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M., & Perry, G. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052212.x · Cited by 547 · see citing works

Alzheimer’s disease: Recent treatment strategies

Vaz, M., & Silvestre, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173554 · Cited by 547 · see citing works

Lipids and Alzheimer’s Disease

Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485 · see citing works

Metal dyshomeostasis and oxidative stress in Alzheimer’s disease

Greenough, M. A., Camakaris, J., & Bush, A. I. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 439 · see citing works

Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins

Butterfield, D. A., & Kański, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00249-4 · Cited by 418 · see citing works

Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics

Butterfield, D. A., Perluigi, M., & Sultana, R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.026 · Cited by 363 · see citing works

Alzheimer’s disease, dementia, and stem cell therapy

Duncan, T., & Valenzuela, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0567-5 · Cited by 342 · see citing works

Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review

Yegambaram, M., Manivannan, B., Beach, T. G., & Halden, R. U. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150204121719 · Cited by 277 · see citing works

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease

Mecocci, P., & Polidori, M. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.006 · Cited by 270 · see citing works

Neurobiology of Alzheimer′s disease

Mohandas, E., Velayudhan, R., & Raghunath, B. (2009) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.44908 · Cited by 270 · see citing works

The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review

dos Santos, J. S., Cirino, J. P. G., Carvalho, P. D. O., & Ortega, M. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565700 · Cited by 258 · see citing works

The Association of Tau With Mitochondrial Dysfunction in Alzheimer’s Disease

Cheng, Y., & Bai, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00163 · Cited by 239 · see citing works

Neuroprotective Natural Products for Alzheimer’s Disease

Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236 · see citing works

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis

Chakravorty, A., Jetto, C. T., & Manjithaya, R. R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00311 · Cited by 219 · see citing works

Alterations in Mitochondrial Quality Control in Alzheimer’s Disease

Cai, Q., & Tammineni, P. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00024 · Cited by 215 · see citing works

Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease

Zhang, L., Trushin, S., Christensen, T. A., Bachmeier, B. V., Gateno, B., Schroeder, A., Yao, J., Itoh, K., Sesaki, H., Poon, W. W., et al. (2016) · Scientific Reports · doi:10.1038/srep18725 · Cited by 198 · see citing works

Gene therapy for neurodegenerative disorders: advances, insights and prospects

Chen, W., Hu, Y., & Ju, D. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.015 · Cited by 191 · see citing works

Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell

Gan, X., Huang, S., Wu, L., Wang, Y., Hu, G., Li, G., Zhang, H., Yu, H., Swerdlow, R. H., Chen, J. X., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.009 · Cited by 181 · see citing works

Mitochondrial DNA mutations in neurodegeneration

Keogh, M. J., & Chinnery, P. F. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.015 · Cited by 163 · see citing works

Protective Effects of a Natural Product, Curcumin, against Amyloid β Induced Mitochondrial and Synaptic Toxicities in Alzheimer'S Disease

Reddy, P. H., Mańczak, M., Yin, X., Grady, M. C., Mitchell, A., Kandimalla, R. J. L., & Kuruva, C. S. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000240 · Cited by 163 · see citing works

Iron and oxidizing species in oxidative stress and Alzheimer's disease

Zhao, Z. (2019) · Aging Medicine · doi:10.1002/agm2.12074 · Cited by 162 · see citing works

A comprehensive review of natural products against atopic dermatitis: Flavonoids, alkaloids, terpenes, glycosides and other compounds

Wu, S., Pang, Y., He, Y., Zhang, X., Li, P., Guo, J., & Zeng, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111741 · Cited by 148 · see citing works

Alzheimer’s disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers

Carvalho, C., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.001 · Cited by 145 · see citing works

The role of mitochondria in neurodegenerative diseases

Filosto, M., Scarpelli, M., Cotelli, M. S., Vielmi, V., Todeschini, A., Gregorelli, V., Tonin, P., Tomelleri, G., & Padovani, A. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6104-z · Cited by 140 · see citing works

Role of mitochondrial dysfunction and dysregulation of Ca2+ homeostasis in the pathophysiology of insulin resistance and type 2 diabetes

Wang, C., & Wei, Y. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0375-3 · Cited by 136 · see citing works

Cannabis Therapeutics and the Future of Neurology

Russo, E. B. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00051 · Cited by 132 · see citing works

Neuroprotective effects of donepezil through inhibition of GSK‐3 activity in amyloid‐β‐induced neuronal cell death

Noh, M., Koh, S., Kim, Y., Kim, H. Y., Cho, G. W., & Kim, S. H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05837.x · Cited by 131 · see citing works

Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies

Yuan, N.-N., Cai, C.-Z., Wu, M.-Y., Su, H., Li, M., & Lu, J. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2510-z · Cited by 127 · see citing works

Brain cells derived from Alzheimer’s disease patients have multiple specific innate abnormalities in energy metabolism

Ryu, W., Bormann, M. K., Shen, M., Kim, D., Forester, B. P., Park, Y., So, J., Seo, H., Sonntag, K., & Cohen, B. M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01068-3 · Cited by 125 · see citing works

Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases

Akkol, E. K., Çankaya, İ. İ. T., Karatoprak, G. Ş., Çarpar, E., Sobarzo‐Sánchez, E., & Capasso, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.669638 · Cited by 122 · see citing works

Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease

Wong, K. Y., Roy, J., Fung, M., Heng, B. C., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1125 · Cited by 119 · see citing works

Insights about clinically approved and Preclinically investigated marine natural products

Ghareeb, M. A., Tammam, M. A., El‐Demerdash, A., & Atanasov, A. G. (2020) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2020.09.001 · Cited by 115 · see citing works

The Interrelation between Reactive Oxygen Species and Autophagy in Neurological Disorders

Fang, C., Gu, L., Smerin, D., Mao, S., & Xiong, X. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8495160 · Cited by 110 · see citing works

On the central role of mitochondria dysfunction and oxidative stress in Alzheimer’s disease

Tobore, T. O. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03863-x · Cited by 110 · see citing works

Exploring the efficacy of natural products in alleviating Alzheimer’s disease

Singh, A., Deshpande, P., & Gogia, N. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253509 · Cited by 108 · see citing works

Natural Products As A Rich Source Of Tau-Targeting Drugs For Alzheimer’s Disease

Calcul, L., Zhang, B., Jinwal, U. K., Dickey, C. A., & Baker, B. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.124 · Cited by 107 · see citing works

Mitochondria in Neuronal Health: From Energy Metabolism to Parkinson's Disease

Mahadevan, H. M., Hashemiaghdam, A., Ashrafi, G., & Harbauer, A. B. (2021) · Advanced Biology · doi:10.1002/adbi.202100663 · Cited by 106 · see citing works

Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage

Hoekstra, J. G., Hipp, M. J., Montine, T. J., & Kennedy, S. R. (2016) · Annals of Neurology · doi:10.1002/ana.24709 · Cited by 103 · see citing works

Lipid peroxidation in neurodegeneration

Peña‐Bautista, C., Vento, M., Baquero, M., & Cháfer‐Pericás, C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.037 · Cited by 100 · see citing works

Curcumin as a Therapeutic Agent in Dementia: A Mini Systematic Review of Human Studies

Brondino, N., Re, S., Boldrini, A., Cuccomarino, A. F., Lanati, N., Barale, F., & Politi, P. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/174282 · Cited by 99 · see citing works

Dietary Modulation of Oxidative Stress in Alzheimer’s Disease

Thapa, A., & Carroll, N. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071583 · Cited by 94 · see citing works

The protective effects of polyphenols on Alzheimer's disease: A systematic review

Colizzi, C. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.09.002 · Cited by 93 · see citing works

Anticancer Drugs Targeting the Mitochondrial Electron Transport Chain

Rohlena, J., Dong, L.-F., Ralph, S. J., & Neuzil, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3990 · Cited by 91 · see citing works

Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy

Liu, D., Chen, L., Zhao, H., Vaziri, N. D., Ma, S., & Zhao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108990 · Cited by 84 · see citing works

Targeting the Prodromal Stage of Alzheimer's Disease: Bioenergetic and Mitochondrial Opportunities

Caldwell, C. C., Yao, J., & Brinton, R. D. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0324-8 · Cited by 83 · see citing works

The genetics of neurodegenerative diseases

Hardy, J., & Orr, H. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03979.x · Cited by 78 · see citing works

Quercetin Exerts Differential Neuroprotective Effects Against H2O2 and Aβ Aggregates in Hippocampal Neurons: the Role of Mitochondria

Godoy, J. A., Lindsay, C. B., Quintanilla, R. A., Carvajal, F. J., Cerpa, W. F., & Inestrosa, N. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0203-x · Cited by 77 · see citing works

Biliverdin reductase‐A: a novel drug target for atorvastatin in a dog pre‐clinical model of Alzheimer disease

Barone, E., Mancuso, C., Di Domenico, F., Sultana, R., Murphy, M. P., Head, E., & Butterfield, D. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07538.x · Cited by 75 · see citing works

Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 72 · see citing works

Mitochondrial integrity in neurodegeneration

Cowan, K., Anichtchik, O. V., & Luo, S. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13105 · Cited by 65 · see citing works

Role of antioxidants and a nutrient rich diet in Alzheimer's disease

Veurink, G., Perry, G. L., & Singh, S. K. (2020) · Open Biology · doi:10.1098/rsob.200084 · Cited by 65 · see citing works

Alzheimer Disease

Morley, J. E., Farr, S. A., & Nguyen, A. D. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.06.006 · Cited by 62 · see citing works

The Role of Dietary Antioxidants in the Pathogenesis of Neurodegenerative Diseases and Their Impact on Cerebral Oxidoreductive Balance

Winiarska‐Mieczan, A., Baranowska‐Wójcik, E., Kwiecień, M., GRELA, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020) · Nutrients · doi:10.3390/nu12020435 · Cited by 61 · see citing works

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease

Lee, J., Kim, H., Kim, J., Yook, T. H., Kim, K. H., Lee, J. Y., & Yang, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031324 · Cited by 59 · see citing works

Natural Products as Potential Anti-Alzheimer Agents

Panda, S. S., & Jhanji, N. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190618113613 · Cited by 58 · see citing works

Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride

Corace, G., Angeloni, C., Malaguti, M., Hrelia, S., Stein, P. C., Brandl, M., Gotti, R., & Luppi, B. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.899369 · Cited by 55 · see citing works

Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer’s disease

Xu, L., Shen, Y., Wang, X., Wei, L., Wang, P., Yang, H., Wang, C.-F., Xie, Z., & Bi, J. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000739 · Cited by 55 · see citing works

Research and Development for Botanical Products in Medicinals and Food Supplements Market

Miroddi, M., Mannucci, C., Mancari, F., Navarra, M., & Calapai, G. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/649720 · Cited by 53 · see citing works

Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective

Abyadeh, M., Gupta, V., Chitranshi, N., Gupta, V., Wu, Y., Saks, D., Wall, R. V., Fitzhenry, M. J., Basavarajappa, D. K., You, Y., et al. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1918550 · Cited by 49 · see citing works

Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders

Nunomura, A., Lee, H., Zhu, X., & Perry, G. L. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160433 · Cited by 46 · see citing works

The roles of FoxOs in modulation of aging by calorie restriction

Kim, D. H., Park, M. H., Lee, E. K., Choi, Y. J., Chung, K. W., Moon, K. M., Kim, M. J., An, H. J., Park, J. W., Kim, N. D., et al. (2014) · Biogerontology · doi:10.1007/s10522-014-9519-y · Cited by 45 · see citing works

Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer’s disease

Handa, M., Tiwari, S., Yadav, A. K., Almalki, W. H., Alghamdi, S. A., Alharbi, K. S., Shukla, R., & Beg, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.020 · Cited by 44 · see citing works

Alzheimer';s Disease and Natural Products: Future Regimens Emerging from Nature

Islam, M. A., Khandker, S. S., Alam, F., Khalil, M. I., Kamal, M. A., & Gan, S. H. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170103163054 · Cited by 43 · see citing works

Exploitation of Marine Molecules to Manage Alzheimer’s Disease

Silva, M., Seijas, P., & Otero, P. (2021) · Marine Drugs · doi:10.3390/md19070373 · Cited by 43 · see citing works

Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis

Shukla, R., Singh, A., Handa, M., Flora, S. J. S., & Kesharwani, P. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.04.011 · Cited by 40 · see citing works

Marine-derived protein kinase inhibitors for neuroinflammatory diseases

Ning, C., Wang, H., Gao, R., Chang, Y., Hu, F., Meng, X., & Huang, S. (2018) · BioMedical Engineering OnLine · doi:10.1186/s12938-018-0477-5 · Cited by 36 · see citing works

Orexin and Alzheimer’s Disease: A New Perspective

Um, Y. H., & Lim, H. K. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0136 · Cited by 34 · see citing works

Altered Ca2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease.

Ibarreta, D., Parrilla, R., & Ayuso, M. S. (1997) · PubMed · Cited by 30 · see citing works

Small Molecule Natural Products and Alzheimer’s Disease

Wu, X., Cai, H., Pan, L., Cui, G., Qin, F., Li, Y., & Cai, Z. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190201153257 · Cited by 29 · see citing works

Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders

Bogdan, A., Manera, V., König, A., & David, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01581 · Cited by 29 · see citing works

An Optimized Method for Histological Detection of Dopaminergic Neurons in Drosophila melanogaster

Drobysheva, D., Ameel, K., Welch, B., Ellison, E., Chaichana, K., Hoang, B., Sharma, S., Neckameyer, W., Srinakevitch, I., Murphy, K. J., et al. (2008) · Journal of Histochemistry and Cytochemistry · doi:10.1369/jhc.2008.951137 · Cited by 28 · see citing works

Lipid Peroxidation Research

Mansour, M. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73713 · Cited by 25 · see citing works

Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases

Behl, T., Kaur, G., Sehgal, A., Singh, S., Bhatia, S., Al‐Harrasi, A., Zengin, G., BUNGAU, S. G., Munteanu, M. A., Brisc, M. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084045 · Cited by 24 · see citing works

Role of Curcumin in Treatment of Alzheimer Disease

Mukhopadhyay, C. D., Ruidas, B., & Chaudhury, S. S. (2017) · International Journal of Neurorehabilitation · doi:10.4172/2376-0281.1000274 · Cited by 23 · see citing works

DNA versus RNA oxidation in Parkinson’s disease: Which is more important?

Gmitterová, K., Gawinecka, J., Heinemann, U., Valkovič, P., & Zerr, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.048 · Cited by 22 · see citing works

Pathway-Specific Genetic Risk for Alzheimer’s Disease Differentiates Regional Patterns of Cortical Atrophy in Older Adults

Caspers, S., Röckner, M. E., Jockwitz, C., Bittner, N., Teumer, A., Herms, S., Hoffmann, P., Nöthen, M. M., Moebus, S., Amunts, K., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz127 · Cited by 22 · see citing works

Exploring the role of mitochondrial proteins as molecular target in Alzheimer’s disease

Chadha, S., Behl, T., Sehgal, A., Kumar, A., & BUNGAU, S. G. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.008 · Cited by 20 · see citing works

The ubiquitous role of mitochondria in Parkinson and other neurodegenerative diseases

Theocharopoulou, G. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2020004 · Cited by 19 · see citing works

Nanomedical Drug Delivery for Neurodegenerative Diseases

(2022) · Elsevier eBooks · doi:10.1016/c2020-0-02783-0 · Cited by 16 · see citing works

Role of Dietary Antioxidants in Neurodegenerative Diseases: Where are We Standing?

Bakır, S., Çatalkaya, G., Ceylan, F. D., Khan, H. Z., Güldiken, B., Çapanoğlu, E., & Kamal, M. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200107143619 · Cited by 15 · see citing works

Design, synthesis and in-vitro evaluation of fluorinated triazoles as multi-target directed ligands for Alzheimer disease

Dalvi, T., Dewangan, B., Agarwal, G., Suchita, D. S., Jain, A. K., Srivastava, A., & Sahu, B. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127999 · Cited by 15 · see citing works

Role of Lipid Peroxidation Process in Neurodegenerative Disorders

Muthuraman, A., Rishitha, N., Paramakrishnan, N., Bhaskaran, M., & Ramesh, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81188 · Cited by 12 · see citing works

Approaches for the treatment of neurodegenerative diseases related to natural products

Majolo, F., Martins, A., Rehfeldt, S. C. H., Henriques, J. A. P., Contini, V., & Goettert, M. I. (2021) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819487-4.00014-8 · Cited by 10 · see citing works

Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times

Nabavi, S. M., & Sobarzo‐Sánchez, E. (2020) · Current Neuropharmacology · doi:10.2174/1570159x1902201231153120 · Cited by 3 · see citing works

From natural products to Alzheimer experimental therapeutics, eserine based drugs as symptomatic and disease altering agents

Greig, N. H., Becker, R. E., Yu, Q., & Holloway, H. W. (2010) · Progress in nutrition · Cited by 3 · see citing works

Calcium Signalling in Alzheimer’s Disease

Chami, M. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0499-5 · Cited by 1 · see citing works

Application of Molecular Simulation Methods in Food Science: Status and Prospects

Yu, Y., Xu, S., He, R., & Liang, G. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06789 · Cited by 111 · see citing works

Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights

Nagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040053 · Cited by 61 · see citing works

Nanozymes in the Treatment of Diseases Caused by Excessive Reactive Oxygen Specie

Liang, S., Tian, X., & Wang, C. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s383239 · Cited by 60 · see citing works

Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases

Shi, W., Tan, C., Liu, C., & Chen, D. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0056 · Cited by 46 · see citing works

Design and development of benzyl piperazine linked 5-phenyl-1,2,4-triazole-3-thione conjugates as potential agents to combat Alzheimer’s disease

Kiran, P. V. R., Waiker, D. K., Verma, A., Saraf, P., Bhardwaj, B., Kumar, H., Singh, A., Kumar, P., Singh, N., Srikrishna, S., et al. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106749 · Cited by 31 · see citing works

Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease

Kamath, A. P., Nayak, P. G., John, J., Mutalik, S., Balaraman, A. K., & Nandakumar, K. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110096 · Cited by 29 · see citing works

Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy

Ali, M., Gowda, B. H. J., Shukla, R., & Kesharwani, P. (2025) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s526895 · Cited by 16 · see citing works

Molecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease

Iyaswamy, A., Wang, X., Zhang, H., Vasudevan, K., Wankhar, D., Lu, K., Krishnamoorthi, S., Guan, X.-J., Su, C.-F., Liu, J., et al. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00479e · Cited by 9 · see citing works

Advances in the Understanding of Mitochondrial Inflammatory Regulation in the Pathogenesis of Alzheimer’s Disease

Zhang, R.-Z., Li, L., Ma, C., Dou, T., Wei, Y.-T., & Yan, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s557000 · Cited by 7 · see citing works

Indole therapeutics: Latest FDA updates, ongoing trials, and future directions

Butt, N.-U.-H., & Baytaş, S. N. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104471 · Cited by 4 · see citing works

Therapeutic targeting of mitochondria–proteostasis axis by antioxidant polysaccharides in neurodegeneration

Wang, Q., Adil, M. Z., Xie, X. S., Zhao, S., Zhang, J., & Huang, Z. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.017 · Cited by 4 · see citing works

Reactive Oxygen Species-Mediated Mitochondrial-Targeted Therapeutics in Hepatic Disorders: Current Progress and Future Opportunities

Dhiman, A., Shah, Y., Chaudhary, U., & Garkhal, K. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00145 · Cited by 3 · see citing works

Exploring the potential nutritional role of bioflavonoids in exercise rehabilitation: a kinematic perspective

Tan, Q., Chen, B., Wu, C., & Shao, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1221800 · Cited by 3 · see citing works

Targeting mitochondrial quality control in Alzheimer’s disease: Mechanisms and therapeutic potential of phytomedicines

Lin, Z., Zhang, S., & Sun, M. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108202 · Cited by 2 · see citing works

Secondary Metabolites

Housseini, A. E., Rachmoune, K., Aitbaba, A., Hamdan, Y. A., Armadi, I., Harkat, C., Laghzaoui, E.-M., Kahime, K., Hidan, M. A. E., Laaradia, M. A., et al. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch005 · Cited by 1 · see citing works

Clinical application and future consideration and potential of cannabis

Dhiman, A., Mittal, G., & Tushir, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15489-8.00012-8 · Cited by 1 · see citing works

Scientific investigation of non-coding RNAs in mitochondrial epigenetic and aging disorders: Current nanoengineered approaches for their therapeutic improvement.

Patange, V., Ahirwar, K., Tripathi, T., Tripathi, P., & Shukla, R. (2024) · Mitochondrion (Amsterdam. Print) · doi:10.1016/j.mito.2024.101979

Bioflavonoid: Extraction Method, Stability, and Biological Activities

Ghosal, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-3663-1_4

Mitochondrial Health in Cardiometabolic Diseases and Aging: Clinical Applications of Therapeutic Fasting and Natural Supplements

Tripathi, A. P., Verma, M., Tripathi, M., & Singh, B. K. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009875

Mitochondria as a therapeutic target for the treatment of Alzheimer's disease

Elufioye, T. O. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00021-1

Mechanism‐Driven Nanoformulations for Cognitive Impairment Induced by Intermittent Hypoxia and Periodontitis

Zhang, K.-R., Zhu, T., Liu, A., Deng, J., Han, Y., Qi, S., Liu, X., Jiang, T., Zhai, M. X., He, Y.-Y., et al. (2026) · Advanced Materials · doi:10.1002/adma.73920

Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer’s disease: A comprehensive review

Jin, X., Guo, J., Wang, L., Zhong, X., Yao, W., Gao, H., & Liu, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113401 · Cited by 29 · see citing works

Mitochondrial dysfunction and oxidative stress in Alzheimer's disease–A step towards mitochondria based therapeutic strategies

Aran, K. R., & Singh, S. (2023) · Aging and Health Research · doi:10.1016/j.ahr.2023.100169 · Cited by 48 · see citing works

Mitochondrial Dysfunction in Alzheimer’s Disease and Progress in Mitochondria-Targeted Therapeutics

Flannery, P. J., & Trushina, E. V. (2019) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-019-00179-0 · Cited by 40 · see citing works

Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 72 · see citing works

Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations

Mani, S., Swargiary, G., Singh, M., Agarwal, S., Dey, A., Ojha, S. K., & Jha, N. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119985 · Cited by 23 · see citing works